Global law firm Greenberg Traurig, P.A. advised OPKO Health Inc., a Miami-based multinational biopharmaceutical and diagnostics company, in negotiating an agreement to sell select assets of its wholly owned subsidiary, BioReference Health, to Labcorp.

Labcorp will acquire BioReference Health’s laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States. The purchase price is up to $225 million, including $192.5 million payable at closing and up to $32.5 million in an earnout based on performance, according to Labcorp’s press release.

The sale is subject to customary closing conditions and is anticipated to close in the second half of 2025.

Click Here To Read The Full Article